BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16215446)

  • 1. Outcomes for medicaid clients with substance abuse problems before and after managed care.
    McFarland BH; Deck DD; McCamant LE; Gabriel RM; Bigelow DA
    J Behav Health Serv Res; 2005; 32(4):351-67. PubMed ID: 16215446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes for clients of public substance abuse treatment programs before and after Medicaid managed care.
    McFarland BH; McCamant LE; Barron NM
    J Subst Abuse Treat; 2005 Mar; 28(2):149-57. PubMed ID: 15780545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of managed care on access to mental health services among Medicaid enrollees receiving substance treatment.
    Bigelow DA; McFarland BH; McCamant LE; Deck DD; Gabriel RM
    Psychiatr Serv; 2004 Jul; 55(7):775-9. PubMed ID: 15232016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to substance abuse treatment services under the Oregon Health Plan.
    Deck DD; McFarland BH; Titus JM; Laws KE; Gabriel RM
    JAMA; 2000 Oct; 284(16):2093-9. PubMed ID: 11042758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oregon's transition to a managed care model for Medicaid-funded substance abuse treatment: steamrolling the glass menagerie.
    D'Ambrosio R; Mondeaux F; Gabriel RM; Laws KE
    Health Soc Work; 2003 May; 28(2):126-36. PubMed ID: 12774534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capitated Medicaid managed care in a rural area: the impact of Minnesota's PMAP program.
    Long SK; Coughlin TA; King J
    J Rural Health; 2005; 21(1):12-20. PubMed ID: 15667005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State Medicaid Programs Bring Managed Care Tenets to Fee for Service.
    Keast SL; Skrepnek G; Nesser N
    J Manag Care Spec Pharm; 2016 Feb; 22(2):145-8. PubMed ID: 27015253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration and its discontents: substance abuse treatment in the Oregon Health Plan.
    Laws KE; Gabriel RM; McFarland BH
    Health Aff (Millwood); 2002; 21(4):284-9. PubMed ID: 12117142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of managed care on the substance abuse treatment patterns and outcomes of Medicaid beneficiaries: Maryland's HealthChoice program.
    Ettner SL; Denmead G; Dilonardo J; Cao H; Belanger AJ
    J Behav Health Serv Res; 2003; 30(1):41-62. PubMed ID: 12633003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial capitation versus fee-for-service in mental health care.
    Shern DL; Donahue SA; Felton C; Joseph GR; Brier N
    Health Aff (Millwood); 1995; 14(3):208-19. PubMed ID: 7498893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol and juvenile justice contacts: a comparison of fee-for-service and capitated medicaid mental health services.
    Scott MA; Snowden LR; Libby AM
    J Stud Alcohol; 2002 Jan; 63(1):44-8. PubMed ID: 11925057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prepaid capitation versus fee-for-service reimbursement in a Medicaid population.
    Badgett JT; Rabalais GP
    Am J Manag Care; 1997 Feb; 3(2):277-82. PubMed ID: 10169262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Savings from a Medicaid carve-out for mental health and substance abuse services in Massachusetts.
    Frank RG; McGuire TG
    Psychiatr Serv; 1997 Sep; 48(9):1147-52. PubMed ID: 9285974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating selection out of health plans for Medicaid beneficiaries with substance abuse.
    Normand SL; Belanger AJ; Frank RG
    J Behav Health Serv Res; 2003; 30(1):78-92. PubMed ID: 12633005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managed Medicaid cost savings: the Arizona experience.
    McCall N; Wrightson CW; Paringer L; Trapnell G
    Health Aff (Millwood); 1994 Spring (II); 13(2):234-45. PubMed ID: 8056377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Here's how to evaluate state Medicaid cap rates--before signing on the dotted line.
    Public Sect Contract Rep; 1997 Sep; 3(9):140-2. PubMed ID: 10174886
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychiatric service utilization and cost for persons with schizophrenia in a Medicaid managed care program.
    Rothbard AB; Kuno E; Hadley TR; Dogin J
    J Behav Health Serv Res; 2004; 31(1):1-12. PubMed ID: 14722476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.